Our results support the hypothesis that DOT1L inhibition suppresses breast cancer cell proliferation by activating STING and types I and III IFN signaling, but further study will be necessary to clarify the effect of DOT1L inhibition in TNBC cells with chromosomal instability. The gene discussed is STING1; the disease is breast carcinoma.